EFdA, a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of Langerhans cells within epithelium.

Takamitsu Matsuzawa Tatsuyoshi Kawamura Youichi Ogawa Kenji Maeda Hirotomo Nakata Kohji Moriishi Yoshio Koyanagi Hiroyuki Gatanaga Shinji Shimada Hiroaki Mitsuya

J Invest Dermatol

Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Infectious Diseases and Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.

Published: April 2014

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370670	PMC
http://dx.doi.org/10.1038/jid.2013.467	DOI Listing

Publication Analysis

Top Keywords

efda reverse

reverse transcriptase

transcriptase inhibitor

inhibitor potently

potently blocks

blocks hiv-1

hiv-1 vivo

vivo infection

infection langerhans

langerhans cells

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!